Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease

by | Dec 6, 2024 | Scientific presentation

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Speaker | Nadia Ashrafi, Ph.D.
Affiliation | Metabolomics Research Group | Corewell Health Research Institute | Corewell Health East William Beaumont University Hospital | Research Scientist


Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease

Part of the
Corewell Health Metabolomics Symposium

Comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s Disease


Related articles

Upcoming events

Arizona Metabolomics Symposium 2026

Date February 20, 2026Time All Day EventVenue Arizona State University

Join us at the Arizona Metabolomics Symposium 2026, an event exploring the latest developments in metabolomics research, its applications in health and metabolism, and fostering collaboration among scientists and the public. Attendees will hear from leading experts and ...

More Info

Annual conference DGMS 2026

Date Mar 10 - 13, 2026Time All Day EventVenue Universität Leipzig

The 57th Annual Conference of the DGMS, dedicated to the diversity and innovative potential of mass spectrometry across instrumentation, analytical strategies, and interdisciplinary applications, will bring together researchers, postdocs and experts for scientific talks...

More Info